Jesús Ruiz-Aragón

4PUBLICATIONS
5CO-AUTHORS
Epidemiological methodsSocial epidemiologyInnate immunityPacific Peoples social determinants of health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 28, 2023
Real-World Evidence in Cost-Effectiveness Analysis of Enhanced Influenza Vaccines in Adults ≥ 65 Years of Age: Literature Review and Expert Opinion.

Maarten Postma, David Fisman, Norberto Giglio

|Feb 26, 2022
Cost-Effectiveness and Burden of Disease for Adjuvanted Quadrivalent Influenza Vaccines Compared to High-Dose Quadrivalent Influenza Vaccines in Elderly Patients in Spain.

Jesús Ruiz-Aragón, Sergio Márquez-Peláez, Ray Gani

|Oct 30, 2020
Reply to letter from Alvarez et al.

Jesús Ruiz-Aragón, Ray Gani, Sergio Márquez

|Feb 11, 2020
Estimated cost-effectiveness and burden of disease associated with quadrivalent cell-based and egg-based influenza vaccines in Spain.

Jesús Ruiz-Aragón, Ray Gani, Sergio Márquez

Pageof 1

Frequent Collaborators

2 joint publications

Sergio Márquez-Peláez

1 joint publications

Norberto Giglio

1 joint publications

Andrea Pugliese

1 joint publications

Analia Urueña